Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Key sources of strength and resilience for persons receiving services for Hansen's disease (leprosy) in Porto Velho, Brazil: What can we learn for service development?

van 't Noordende A, Pereira Z, Kuipers P. International health. 2021;
Download PDF
Publication

Hansen's disease in the era of COVID-19: An observation on a series of six patients with co-infection.

Arora S, Bhatnagar A, Singh G, et al. Dermatologic therapy. 2021;
Download PDF
Publication

Persons affected by leprosy and the COVID-19 global health crisis: a consultative calls report from GPZL’s emergency response Working Group 2

Tucker A, Cruz A, Duck M, et al. Lepra. Leprosy Review. 2020; 91 (4) : 425-430.
Download PDF
Publication

HANSENÍASE: O ACOLHIMENTO COMO BOA PRÁTICA EM QUADROS CLÍNICOS PRECURSORES DE PRECONCEITO

Schmitt NM, Araújo LDC, Ferreira FADA, et al. Atena Editora. A Medicina imersa em um Mundo Globalizado em Rápida Evolução 2. 2021;
Download PDF
Publication

Reversal reaction with nodules that initially diagnosed as erythema nodosum leprosum in borderline lepromatous leprosy

Tsaqilah L, Achdiat P, Gunawan H. Journal of General-Procedural Dermatology & Venereology. Journal of General-Procedural Dermatology and Venereology Indonesia. 2020; 5 (1) : 68-73.
Download PDF
Publication

Leprosy in Kiribati: the lived experience

Thompson L, Ioteba N, Chambers S. Lepra. Leprosy Review. 2020; 91 (4) : 353-366.
Download PDF
Publication

Hanseníase: Direitos Humanos, Saúde e Cidadania

Sousa ACM, Brandão P, Duarte NIG. Rede Unida. Série Interlocuções Práticas, Experiências e Pesquisas em Saúde. 2020;
Download PDF
Publication

PERFIL EPIDEMIOLÓGICO DA HANSENÍASE EM UM MUNICÍPIO DA REGIÃO NORTE DO BRASIL / EPIDEMIOLOGICAL PROFILE OF LEPROSY IN A MUNICIPALITY IN NORTHERN BRAZIL

Sá SC, Silva DDS. Brazilian Journal of Development. Brazilian Journal of Development. 2021; 7 (1) : 8959-8974.
Download PDF
Publication

ESTIGMA SOBRE A MULHER PORTADORA DE HANSENIASE: UM ESTUDO DO ASILO COLÔNIA LAURO DE SOUZA LIMA

Jordão da Silva M. Canoa do Tempo. Revista Canoa do Tempo. 2021; 12 (2) : 267-281.
Download PDF
Publication

ÁREAS PRIORITÁRIAS PARA CONTROLE DA HANSENÍASE NO MUNICÍPIO DE JABOATÃO DOS GUARARAPES, PERNAMBUCO, BRASIL, 2017

Carneiro GR, Francisco MM, Oliveira ALDSD, et al. Atena Editora. Condições Teórico-Práticas das Ciências da Saúde no Brasil. 2020;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 311
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD